Graeme McLean
Vice President, Commercial
@
Ansa Biotechnologies
About Graeme McLean
Graeme McLean serves as the Vice President, Commercial at a company specializing in innovative DNA synthesis technology, a position he assumed in February 2024.
Known information
Graeme McLean was appointed as the Vice President, Commercial in February 2024. In this role, he is a key member of an interdisciplinary team dedicated to advancing the field of DNA synthesis technology. McLean works closely with notable team members including Jason T. Gammack, the CEO; Dan Lin-Arlow and Sebastian Palluk, both co-founders and respectively serving as Chief Scientific Officer and Chief Technology Officer; Jeremiah Hanes, the Senior Vice President of Research and Development; Marcos Urias, Vice President of Manufacturing; Yves Lacroix, Vice President of Engineering; Jessica Krack, Head of HR; Nick Hurt, General Counsel and Head of Intellectual Property; John Trust, Director of Finance; and Jared Ellefson, Head of DNA Assembly and co-founder. His role involves strategic commercial activities that support the company’s mission to innovate within the biotechnology industry.
About Ansa Biotechnologies
Ansa Biotechnologies, based in Emeryville, CA, specializes in enzyme-based DNA synthesis, focusing on sequences that are challenging to produce with existing methods. The company, part of the Y Combinator W20 batch, has raised $68 million in Series A financing to expand its innovative DNA synthesis technology.